Info

🌱 來自: risk-enhancing factors for clinician–patient risk discussion

lipid biomarkers that associated with increased ASCVD risk

Persistently* elevated, primary hypertriglyceridemia (2175 mg/dL); if measured:

1. Elevated high-sensitivity C-reactive protein (≥2.0 mg/L) 2 Elevated Lp(a): A relative indication for its measurement is family history of premature ASCVD. An Lp(a) ≥50 mg/dL Ol ≥125 nmolL constitutes a risk-enhancing factor especially at higher levels of Lp(a).
2. Elevated apoB ≥130 mg/dL: A relative indication for its measurement would be triglyceride 2200 mg/dL. A level ≥130 mg/ dL corresponds to an LDL-C ≥160 mg/dL and constitutes a riskenhancing factor.
3. ABI <0.9